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Aims Lack of response to cardiac resynchronization therapy (CRT) may be due to the presence of signifi-
cant amount of scar or fibrotic tissue at myocardial level. This study sought to investigate the potential
impact of myocardial contractile reserve as assessed during exercise echocardiography on left ventricu-
lar (LV) reverse remodelling (decrease in LV end-systolic volume 15% after 6 months of CRT).
Methods and results Fifty-one consecutive patients with heart failure underwent exercise Doppler
echocardiography before CRT implantation to assess global contractile reserve and local contractile
reserve (assessed by two-dimensional speckle tracking) in the region of the LV pacing lead. Responders
(30 patients) showed a greater exercise-induced increase in left ventricular ejection fraction (LVEF)
compared with non-responders (P , 0.001). Contractile reserve was directly related to the improve-
ment in LVEF and to LV reverse remodelling after 6 months of CRT (P, 0.001). A 6.5% exercise-
induced increase in LVEF yielded a sensitivity of 90% and a specificity of 85.7% to predict the response
after 6 months of CRT. Baseline myocardial deformation as well as contractile reserve in the LV pacing
lead region was greater in responders than in non-responders (P , 0.0001).
Conclusion Myocardial contractile reserve (global and regional) is a strong predictive factor of LV










Cardiac resynchronization therapy (CRT) has significantly
changed the treatment of patients with end-stage heart
failure.1 Currently, CRT is an adjunctive treatment indicated
for treating patients with heart failure and significant ven-
tricular conduction delay who remain symptomatic,
despite optimal drug therapy.2 CRT improves clinical
status, quality of life and exercise capacity, prolongs survi-
val, and promotes various haemodynamic and structural
ventricular changes.3,4 Reduction in left ventricular
(LV) end-systolic volume—LV reverse remodelling—after
6 months under stimulation is a major determinant of long-
term survival after CRT.5 However, still 30% of patients do
not present LV reverse remodelling, and thus do not
respond to CRT. Response to CRT largely depends on the
extent of LV dyssynchrony, the severity of LV remodelling,
and the possibility offers to the LV to recruit function.6,7
CRT response could thus correlate with myocardial viability
and inversely be associated with the extent of myocardial
fibrosis.8,9 Furthermore, scar tissue or fibrosis—character-
ized by lack of contractile reserve—in the LV pacing lead
region may prohibit response to CRT. Myocardial contractile
reserve— important prognostic marker in heart failure—can
be reliably assessed during exercise echocardiography.10
This study sought to investigate the potential impact of myo-
cardial contractile reserve—global and in the LV pacing




From March 2004 to January 2008, 133 patients were planned for a
biventricular pacing implantation according to available recommen-
dations. Fifty-five of them who met the following criteria were
enrolled in the present study: (i) NYHA functional class III/IV heart
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failure, (ii) QRS duration 120 ms, (iii) chronic LV systolic dysfunc-
tion (ejection fraction 35%), (iv) optimal medical treatment for
heart failure, (v) sinus rhythm, and (vi) capable of exercising. Exclu-
sion criteria were: (i) recent myocardial infarction (,6 months), (ii)
recent coronary revascularization (,6 months), (iii) poor echogeni-
city, (iv) haemodynamic instability, and (v) atrial fibrillation. Four
patients were subsequently excluded for the failure of CRT implan-
tation. The final population consisted of the 51 remaining patients.
The aetiologies of heart failure were idiopathic dilated cardiomyo-
pathy in 17 patients and ischaemic heart disease in 34 patients.
All patients underwent exercise Doppler echocardiography before
CRT implantation to assess global LV contractile reserve [(improve-
ment in left ventricular ejection fraction (LVEF)] and local contrac-
tile reserve in the region of the LV pacing lead (assessed by
longitudinal strain using speckle tracking analysis). No patients
with ischaemic disease presented inducible ischaemia during
the test. The protocol was approved by the Human Ethical
Committee of our University Hospital and all patients gave informed
consent.
Exercise echocardiography
A symptom-limited graded bicycle exercise test was performed in a
semi-supine position on a tilting exercise table. After an initial
workload of 25 W maintained for 2 min, the workload was increased
every 2 min by 25 W. Blood pressure and a 12-lead electrocardio-
gram were recorded every 2 min. Two-dimensional echocardio-
graphic recordings were made throughout the test.
Echocardiographic measurements
All echocardiographic parameters were obtained at rest and at peak
exercise in the same cycling semi-supine position (Vivid 7 imaging
device, GE Healthcare, UK) and were obtained in digital format
and stored on optical disks for off-line analysis. Two-dimensional
grayscale images (frame rates 70 s21) and colour-tissue Doppler
imaging (frame rates 115 s21) were performed in the apical
views using a narrow sector angle. Left ventricular end-diastolic
and end-systolic volumes and ejection fraction were measured by
the biapical Simpson disk method. Wall motion score analysis was
applied to a 16-segment model of the LV with a semi-quantitative
scoring system (1 ¼ normal, 2 ¼ hypokinesia, 3 ¼ akinesia, and
4 ¼ dyskinesia). To determine LV dyssynchrony with colour-tissue
Doppler imaging, the sample volume (6  6 mm) was placed in the
LV basal parts of the anterior, inferior, septal, and lateral walls
(using the two- and four-chamber apical views), and the time inter-
val between the onset of the QRS complex and the peak systolic vel-
ocity per region was derived (i.e. the electrosystolic delays).
Intra-LV dyssynchrony was referred to LV dispersion and was calcu-
lated as the difference between the longest and the shortest
times to peak systolic velocities of four opposing basal walls.11
Global LV contractile reserve was expressed as the change in LVEF
from rest to peak exercise. Regional contractile reserve in the
pacing lead was assessed using speckle tracking analysis from LV
long-axis images (mid-segments). After tracing the endocardial
borders in the end-systolic frame, an automated tracking algorithm
outlined the myocardial deformation in the dedicated LV seg-
ments.12 Peak systolic longitudinal strain was only measured in
the lateral, posterior, and anterior regions, where the LV lead was
positioned. Aortic and pulmonary Doppler flows were recorded in
the pulsed mode from the apical four-chamber view and parasternal
short-axis view, respectively. The aortic and pulmonary ejection
delays (interventricular dyssynchrony) were defined as the delay
between the onset of the QRS complex or the surface ECG and
the onset of the aortic and pulmonary waves. Quantitation of
mitral regurgitation was performed by the proximal isovelocity
surface area method.4
Cardiac resynchronization therapy implantation
and setting
All patients received a biventricular pacing device for CRT with a
right ventricular apical lead and LV pacing electrodes positioned
through the coronary sinus in a LV epicardial vein. This coronary
sinus lead was placed in a lateral position in 32 patients, in a poster-
olateral position in 16 and in anterior position in 3. After a success-
ful implant, echocardiography was used to optimize the
atrioventricular delay in order to maximize LV filling time. Interven-
tricular pacing interval was set to a default value (V-V ¼ 0 ms). One
day after implantation, the LV lead position was assessed from a
chest X-ray. Using the frontal and lateral views (scored anterior,
lateral, or posterior), we determined the LV lead locations. To
note six patients received a defibrillator.
Follow-up and cardiac resynchronization therapy
response definition
Follow-up clinical and echocardiographic examinations were
obtained at 6 months. Responders were defined by a 15% decrease
in LV end-systolic volume.5 During this period, no patient died nor
was rehospitalized for either heart failure or significant
arrhythmias.
Statistical analysis
Data are expressed as mean+1 SD (STATISTICA version 6). Student’s
paired two-tailed t-test was used to compare measurements
obtained at rest and during exercise. Categorical variables were
compared with Fisher’s exact test. A value of P , 0.05 was con-
sidered significant. Categorical data are summarized as frequencies
and percentages. Linear regression analysis was performed to evalu-
ate the relation between the improvement in LVEF during exercise
and changes in LV end-systolic volume after 6 months of CRT. The
optimal improvement in LVEF and in myocardial strain during exer-
cise to predict response to CRTwas determined by receiver operat-
ing characteristic (ROC) curve analysis. To detect independent
cofactors associated with response to CRT, a logistic multivariate
analysis was performed. All significant variables were included in
the multivariate model. Reproducibility of echocardiographic
measurements has been previously published.13
Results
Table 1 summarizes the baseline characteristics in the
studied population. Patients were predominantly of male
sex and were in general optimally treated.
Response to cardiac resynchronization therapy
During follow-up, the NYHA class improved from 3.06+0.24
to 2.3+0.8 (P , 0.0001). The LVEF improved significantly
from 27+5 to 34+7% (P, 0.001), and significant
reductions in LV end-diastolic (184+39 to 172+38 mL;
P, 0.001) and LV end-systolic volume (134+31 to 114+
32 mL; P , 0.001) were observed. Thirty patients were
classified as responders to CRT, according to the predefined
criterion of a reduction in LV end-systolic volume.
Responders vs. non-responders
Baseline clinical and echocardiographic parameters
between responders and non- responders were similar,
except for higher degree of interventricular mechanical
delay and mitral regurgitation and better myocardial defor-
mation by two-dimensional speckle tracking in the LV lead
region in responders (Table 2). During exercise, responders
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showed a greater increase in LVEF. Improvement in LVEF at
peak test was correlated to the improvement in LV end-
systolic volume after CRT (r ¼ 0.61) (Figure 1). An increase
in LVEF during exercise by 6.5% (ROC curve) yielded a
good sensitivity (90%) and specificity (85.7) for predicting
LV reverse remodelling after CRT (Figure 2). Responders pre-
sented more LV dyssynchrony at baseline than non-
responders. The area under the curve for LV dispersion was
0.88, and the optimal cut-off value to predict response to
CRT was 80 ms, yielding a sensitivity and specificity of 73.3
and 95.2%, respectively. By multivariate logistic regression
analysis, LV dyssynchrony (OR ¼ 0.92, 95% CI: 0.87–0.98;
P ¼ 0.012) and the presence of contractile reserve at
exercise (OR ¼ 0.24, 95% CI: 0.08–0.75; P ¼ 0.017)
emerged as independent predictors of response to CRT.
Among responders, 25 patients had both LV dyssynchrony
and global contractile reserve at exercise (Figure 3). Non-
responders were characterized by no significant LV dyssyn-
chrony and no contractile reserve.
Regional contractile reserve and response
to cardiac resynchronization therapy
During exercise, the extent of improvement in regional
strain (3.6+1.8 vs. 20.26+3.3; P, 0.0001) was greater
in patients who presented reverse LV remodelling at




(n ¼ 30, 59%)
Non-responders
(n ¼ 21, 41%)
P-value
Age (years) 70+9 70+8 69+9 0.85
Male [n (%)] 32 (63) 20 (67) 12 (57) 0.56
Ischaemic cardiomyopathy [n (%)] 34 (67) 17 (57) 17 (85) 0.07
QRS duration (ms) 161+25 154+24 169+25 0.03
Diuretic [n (%)] 42 (82) 23 (77) 19 (90) 0.28
b-Blockers [n (%)] 44 (86) 26 (87) 18 (86) 0.68
ACEi [n (%)] 41 (80) 24 (80) 17 (81) 0.61
AR blockers [n (%)] 5 (9.8) 3 (10) 2 (9.5) 0.68
Spironolactone [n (%)] 23 (45) 14 (47) 9 (43) 0.51
LV–RV dyssynchrony (ms) 52+16 56+16 46+15 0.029
LV–RV  40 ms 36 (71) 24 (80) 12 (57) 0.039
LV dispersion (ms) 85+47 111+39 48+29 ,0.0001
LV dispersion  80 ms 28 (55) 24 (80) 4 (19) ,0.0001
Mitral effective regurgitant orifice (mm2) 18+11 23+10 14+9 0.011
Ischaemic cardiomyopathy: ACEi, angiotensin-converting enzyme inhibitors and AR, angiotensin receptors; LV, left ventricle; RV, right ventricle.




(n ¼ 30, 59%)
Non-responders
(n ¼ 21, 41%)
P-value
LV function
LV end-diastolic volume at rest (mL) 184+39 183+41 186+37 0.80
LV end-diastolic volume at exercise (mL) 180+40 179+43 182+36 0.79
LV end-diastolic volume diff. (mL) 23.9+7.5 23.9+7.5 23.7+6.7 0.90
LV end-systolic volume at rest (mL) 134+32 133+34 134+28 0.95
LV end-systolic volume at exercise (mL) 120+30 118+33 124+27 0.45
LV end-systolic volume diff. (mL) 14+7 16+7 10+5.3 0.001
LV ejection fraction at rest (%) 27.4+5.1 27.1+5.2 27.7+5.0 0.68
LV ejection fraction at exercise (%) 34+6 35+5.7 31+4.7 0.009
LV ejection fraction diff. (%) 6.2+3.3 8.2+2.3 3.5+2.4 ,0.0001
Number of akinetic segments
Rest 6.5+4 6.9+3.3 5.9+3.4 0.26
Exercise 5.1+3.1 4.8+2.9 5.5+3.3 0.47
Wall motion score index
Rest 2.24+0.3 2.25+0.29 2.23+0.32 0.91
Exercise 2.1+0.36 1.9+0.35 2.2+0.33 0.008
Diff. 20.21+0.25 20.3+0.27 20.08+0.13 0.0009
Strain target LV lead wall (%)
Rest 12.7+5.4 14.1+3.8 10.6+6.7 0.023
Exercise 14.9+7.5 18.0+3.4 10.4+9.3 0.00017
Diff. 2.1+3.2 3.8+1.8 20.26+3.3 ,0.0001
LV, left ventricle; Diff, difference between exercise and rest.
Myocardial contractile reserve during exercise 665
follow-up. An exercise increase in strain values of the target
LV lead wall by .2% (ROC curve) yielded a good sensitivity
(86.7%) and specificity (81%) for predicting LV reverse remo-
delling after CRT (Figure 4). Among responders, 22 patients
had both LV dyssynchrony and regional contractile reserve at
exercise (Figure 5). Figure 6 showed a patient without pos-
terolateral contractile reserve during exercise. By multi-
variate logistic regression analysis, LV dyssynchrony (OR ¼
0.96, 95% CI: 0.93–0.98; P ¼ 0.0007) and the presence of
contractile reserve in the LV lead region at exercise (OR ¼
0.39, 95% CI: 0.19–0.81; P ¼ 0.013) emerged as independent
predictors of response to CRT.
Discussion
Response to CRT is modulated by several factors. In the
present study, we confirm that the chronic benefit to CRT
depends in part on the presence of residual myocardial via-
bility and the degree of LV dyssynchrony. A direct relation-
ship existed between the extent of myocardial contractile
recruitment during exercise echocardiography and the
extent of LV reverse remodelling. Conversely, the absence
of contractile reserve, particularly in the region of the LV
pacing lead, is likely associated with no or less reduction
in LV end-systolic volume after CRT.
Role of left ventricular dyssynchrony
Several studies have demonstrated that the major predictor
of responsiveness to CRT is mechanical rather than electrical
dyssynchrony.7,11,14 Among available techniques, tissue
Doppler imaging has emerged as the most practical
method for assessing LV dyssynchrony. As reported pre-
viously, we found that a significant mechanical delay
between the basal segments of the LV, mainly the septum
and the lateral wall, on tissue Doppler was highly predictive
for response to CRT.7,15 Patients with a delay 80 ms showed
Figure 1 Relationship between contractile reserve (improvement
in left ventricular ejection fraction during exercise) at inclusion
and left ventricular reverse remodelling (improvement in left ven-
tricular end-systolic volume) after 6 months of cardiac resynchroni-
zation therapy.
Figure 2 Receiver operating characteristic curve analysis on left
ventricular dyssynchrony to predict the response after cardiac
resynchronization therapy.
Figure 3 Number of responders to cardiac resynchronization
therapy for four different patient categories based on the presence
or absence of left ventricular dyssynchrony (DYSþ/DYS2) in combi-
nation with the presence or absence of global contractile reserve
(CRþ/CR2).
Figure 4 Receiver operating characteristic curve analysis on con-
tractile reserve in the region of the lead pacing (improvement in
regional strain during exercise) to predict the response after
cardiac resynchronization therapy.
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a significant improvement in LV function and a considerable
LV reverse remodelling after 6 months of CRT. However,
although this beneficial effect was rarely observed in
patients with a delay ,80 ms, 20% of the patients with
severe LV dyssynchrony did not respond to CRT. This empha-
sizes that other factors play a role; LV dyssynchrony is
necessary but not sufficient for CRT response. Indeed,
delayed wall motion is mainly a marker of myocardial dys-
function and could be exhibited in viable and scar tissue
according to loading conditions.16,17
Global myocardial reserve and response to cardiac
resynchronization therapy
In patients with depressed LV function, the identification of
contractile reserve during dobutamine stress echocardiogra-
phy has been shown to provide important prognostic
information in both ischaemic and non-ischaemic cardio-
myopathy.18,19 More specifically, in patients with heart
failure referred to CRT, few authors have reported that
the presence of residual myocardial viability might modu-
late the response to CRT.9,12,20–24 Contractile reserve is a
specific marker of underlying myocardial viability, which
can be reliably assessed during semi-supine exercise echo-
cardiography.10 To the best of our knowledge, this study
was the first to examine the value of exercise echocardio-
graphy for predicting response to CRT. Global contractile
reserve was characterized by the increase in LV ejection
during exercise. An increase in LVEF by 6.5% was found
to be predictive for significant LV reverse remodelling
under stimulation. Moreover, the extent of LV global con-
tractile reserve was related to the degree of improvement
in LV function. These data confirm and extend previous
studies by demonstrating that a substantial amount of
recruitable myocardium is needed to obtain improvement
in LV function after CRT. It could be thus argued that in
case of advanced myocardial remodelling process, fibrosis
and loss of contractile material may severely altered myo-
cardial conduction and contractile properties, which might
in turn impede efficient biventricular pacing.25
Role of the viability in the region of the pacing lead
Assessment of regional viability in patients referred to CRT is
not of routine practice. However, few authors have recently
emphasized that viability of the stimulated LV area seems to
be required to obtain successful CRT response.20–24 Indeed,
patients with transmural scar in the posterolateral region
as assessed by contrast-enhanced magnetic resonance
imaging did not improve under stimulation.8,23 Similarly,
the absence of contractile reserve in the region of the LV
pacing as manifested by no significant changes in wall
motion score9 or in two-dimensional strain12 during dobuta-
mine infusion precludes LV reverse remodelling in the
majority of patients. In line with these data, we found
that responders to CRT showed a greater increase in strain
in the region of the LV pacing lead during exercise when
compared with non-responders. An increase in local strain
by 2% was found to be predictive for significant LV
reverse remodelling under stimulation.
Study limitations
Some limitations should be acknowledged. Our data pertain
only to patients with current criteria for CRT implantation
and who were able to exercise. As a result, our population
represents a small subset of heart failure patients submitted
to CRT. The high sensitivity and specificity to predict
response to CRT reported in our study might reflect this
bias of patient selection. These data should, furthermore,
be confirmed in larger series of patients. The population
studied was not completely homogenous since it was com-
posed of patients with myocardial dysfunction of ischaemic
and non-ischaemic origin. However, this represents our
daily patients referred for CRT. Moreover, biventricular
pacing is still a challenging therapy in both settings.
Although, the accuracy of X-ray for assessing the lead pos-
ition is imperfect, there was a good correlation between
Figure 5 Number of responders to cardiac resynchronization
therapy for four different patient categories based on the presence
or absence of left ventricular dyssynchrony (DYSþ/DYS2) in combi-
nation with the presence or absence of contractile reserve in the
region of the pacing lead (LEADþ/LEAD2).
Figure 6 Example of a patient without contractile reserve in the region of the lead pacing. There is no increase in two-dimensional speckle
tracking strain at exercise in the posterolateral wall (POST). SEP, septum.
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viability in the lead region and response to CRT. Since only
one patient had a right bundle branch block, the influence
of this pattern on CRT response could not be analysed.
Conclusions
In heart failure patients with LV systolic dysfunction,
response to CRT required both the presence of LV dyssyn-
chrony and preserved contractile reserve in the region of
the LV pacing. It might thus be proposed that the detection
of myocardial viability as well as the assessment of LV dys-
synchrony should be routinely performed before CRT to
guide LV-pacing lead implantation.
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